Location: Rodd Brudenell River Resort, Georgetown Royalty, PEI
Sunday, July 7, 2013
10:00 am – Golf Classic – Brudenell River Golf Course
4:00-8:00 pm – Registration & Partnering Help Desk Open (Main Hotel Meeting & Convention Centre)
7:00 pm – Greetings from Atlantic Canada Opportunities Agency
Public Lecture – Patrick L. McGeer, MD, PhD, FRCP(C), FRSC (University of British Columbia, Canada) – How can you Maintain a Healthy Brain and Avoid Dementia?
(Montague/Georgetown Room – Main Hotel Meeting & Convention Centre)
7:30 – Registration & Partnering Help Desk Open – (Brudenell/Dundarave Room – Brudenell Golf & Convention Centre Foyer)
7:30 – 8:15 am – Registration & Breakfast (Brudenell/Dundarave Room – Brudenell Golf & Convention Centre)
8:15 – 8:30 am – Opening Remarks – (Brudenell/Dundarave Room – Brudenell Golf & Convention Centre)
8:30 – 9:00 am – Patrick L. McGeer, MD, PhD, FRCP(C), FRSC (University of British Columbia, Canada) The Amyloid Cascade-neuroinflammatory Hypothesis of Alzheimer Disease: Implications for Therapy
9:00 – 9:30 am – Jeff H. Kordower, PhD, (Rush University Medical Center, US) Trophic Factor Gene Therapy for Parkinson’s Disease
9:30 – 10:00 am – Nutrition & Networking Break
10:00 – 12:00 pm – Investing in CNS Sector Presentations
- Johnson & Johnson – Jennifer Hamilton, PhD, Advisor, External Innovation (Canada)
- Galantos Pharma – Alfred Maelicke, PhD, CEO (Germany)
- Lumira Capital – Jacki Jenuth, PhD, Senior Analyst (Canada
- Advinus – Rashmi Barbhaiya, PhD, CEO & Managing Director (India)
12:00 – 1:00 pm – Lunch – (Montague/Georgetown Room – Main Hotel Meeting & Convention Centre)
12:55 – 2:15 pm – One-to-One Partnering Meetings – (Gordon Room – Main Hotel Meeting & Convention Centre – Lower Level)
2:15 – 2:45 pm – George S. Robertson, PhD, (Dalhousie University, Canada) Target-based Selection of Flavonoids for Neurodegenerative Disorders – (Brudenell/Dundarave Room – Brudenell Golf & Convention Centre)
2:45 – 3:15 pm – A. Jon Stoessl, CM, MD, FRCPC, FAAN, (University of British Columbia, Canada) Imaging Biomarkers in Neurodegenerative Disorders
3:15 – 3:30 pm – Nutrition & Networking Break
3:30 – 4:00 pm – Leonard Petrucelli, PhD, (Mayo Clinic, US) Understanding the PGRN/Sortilin Axis as Attractive Therapeutic Target for FTD
4:00 – 4:30 pm – Mike Salter, MD, PhD, (University of Toronto, Canada) Neuro-immune Signaling in Pain Neuroplasticity
4:30 – 5:00 pm – Denis G. Kay, PhD (Neurodyn, Canada) Development of Neuroprotectant Based Therapies for Neurodegenerative Diseases
6:30 p.m. – Beachside BBQ & Lobster Social (Brudenell River Resort Day Use Center)
Tuesday, July 9, 2013
7:30 am: Registration & Partnering Help Desk Open – (Brudenell/Dundarave Room – Brudenell Golf & Convention Centre Foyer)
7:30 – 8:15 am – Breakfast – (Brudenell/Dundarave Room – Brudenell Golf & Convention Centre)
8:30 – 9:00 am Luigi Zecca, MD, PhD, (Institute of Biomedical Technologies, National Research Council, Italy) The Role of Neuromelanin in Brain Aging and Neurodegeneration – (Brudenell/Dundarave Room – Brudenell Golf & Convention Centre)
9:00 – 9:30 am – Yehuda Shoenfeld, MD, FRCP, (Zabludowicz Center for Autoimmune Diseases, Sheba Medical Centre; Sacker Faculty of Medicine, Tel-Aviv University, Israel) The ASIA Syndrome: Autoimmune syndromes Induced by adjuvants
9:30 – 10:00 am – Dwain K. Morris-Irvin, PhD, MPH (Cedars-Sinai Medical Center, Los Angeles) T-lymphocytes influence Behavioral Deficits in the 6-OHDA Unilateral Lesion Model for Parkinson’s disease
10:00 – 10:30 am – Nutrition & Networking Break
10:30 – 12:30 pm – Investing in CNS Sector Presentations
- Genzyme – Stacy Coen, Vice President, Global Head of Business Development, MS (US)
- Delivra – Joe Gabriele, PhD, Chief Scientific Officer (Canada)
- CRP-40 – David Baranowski, Senior Scientist and V.P. Alan Brousseau, V.P. Corporate Development
- BioExpert – Andreas Köpke, PhD, Managing Director (Germany)
- Vitrak Systems – Crystal Lavallee, CEO (Canada)
12:30 – 1:30 pm – Lunch – (Montague/Georgetown Room – Main Hotel Meeting & Convention Centre)
1:30 – 3:10 pm – One-to-One Partnering Meetings – (Gordon Room – Main Hotel Meeting & Convention Centre – Lower Level)
3:10 – 3:40 pm – Stephen J. Crocker, PhD, (University of Connecticut Health Center, US) Regulating Astrocytic Inflammation to Promote CNS Remyelination – (Brudenell/Dundarave Room – Brudenell Golf & Convention Centre)
3:40 – 4:10 pm – Alain Simard, PhD, (Université de Moncton, Canada) α9- and β2-nicotinic Acetylcholine Receptors Differentially Modulate EAE
4:10 – 4:25 pm – Closing Remarks